No current evidence supporting risk of using Ibuprofen in patients with COVID-19

Int J Clin Pract. 2020 Oct;74(10):e13576. doi: 10.1111/ijcp.13576.

Authors

Paulo Ricardo Martins-Filho¹, Edmundo Marques do Nascimento-Júnior¹, Victor Santana Santos²

Affiliations

¹ Investigative Pathology Laboratory, Federal University of Sergipe, Brazil.
² Centre for Epidemiology and Public Health, Federal University of Alagoas, Arapiraca, Brazil.

No abstract available

Publication types

Letter
Comment

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal
Betacoronavirus
COVID-19
Coronavirus Infections*
Diabetes Mellitus*
Humans
Hypertension*
Ibuprofen
Pandemics*
Pneumonia, Viral*
SARS-CoV-2

Substances

Anti-Inflammatory Agents, Non-Steroidal
Ibuprofen